Naoki Toyooka

3.2k total citations
186 papers, 2.5k citations indexed

About

Naoki Toyooka is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Naoki Toyooka has authored 186 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Organic Chemistry, 82 papers in Molecular Biology and 23 papers in Pharmacology. Recurrent topics in Naoki Toyooka's work include Chemical synthesis and alkaloids (38 papers), Synthetic Organic Chemistry Methods (26 papers) and Asymmetric Synthesis and Catalysis (24 papers). Naoki Toyooka is often cited by papers focused on Chemical synthesis and alkaloids (38 papers), Synthetic Organic Chemistry Methods (26 papers) and Asymmetric Synthesis and Catalysis (24 papers). Naoki Toyooka collaborates with scholars based in Japan, United States and United Kingdom. Naoki Toyooka's co-authors include Hideo Nemoto, Takefumi Momose, Yûji Matsuya, Takuya Okada, H. Martin Garraffo, John W. Daly, Hiroshi Tsuneki, Toshiyasu Sasaoka, Dejun Zhou and Kenji Sugimoto and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Naoki Toyooka

178 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Naoki Toyooka Japan	27	1.4k	906	286	208	205	186	2.5k
Satoshi Yokoshima Japan	38	2.9k 2.0×	1.2k 1.4×	601 2.1×	595 2.9×	173 0.8×	140	4.1k
Ae Nim Pae South Korea	33	1.8k 1.3×	1.8k 1.9×	482 1.7×	166 0.8×	94 0.5×	210	3.8k
Raymond Baker United Kingdom	30	1.8k 1.3×	1.4k 1.5×	267 0.9×	82 0.4×	89 0.4×	145	3.3k
Ki Duk Park South Korea	30	695 0.5×	1.1k 1.2×	419 1.5×	118 0.6×	171 0.8×	116	2.7k
Hidenori Watanabe Japan	30	1.0k 0.7×	1.1k 1.2×	653 2.3×	86 0.4×	166 0.8×	136	2.5k
Bruno Pfeiffer France	36	2.4k 1.7×	1.6k 1.8×	483 1.7×	90 0.4×	42 0.2×	145	3.8k
Hiroki Takahata Japan	33	2.8k 2.0×	1.3k 1.4×	224 0.8×	163 0.8×	27 0.1×	199	3.8k
Howard B. Broughton United States	27	899 0.6×	1.2k 1.3×	156 0.5×	68 0.3×	64 0.3×	92	2.4k
František Hubálek Denmark	28	868 0.6×	1.7k 1.8×	490 1.7×	92 0.4×	220 1.1×	55	3.3k

Countries citing papers authored by Naoki Toyooka

Since Specialization

Citations

This map shows the geographic impact of Naoki Toyooka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Toyooka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Toyooka more than expected).

Fields of papers citing papers by Naoki Toyooka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Toyooka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Toyooka. The network helps show where Naoki Toyooka may publish in the future.

Co-authorship network of co-authors of Naoki Toyooka

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Toyooka. A scholar is included among the top collaborators of Naoki Toyooka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Toyooka. Naoki Toyooka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsubota, Maho, Kana Sasaki, Eun-Kyung Shin, et al.. (2025). HMGB1 derived from macrophages and enteric glial cells contributes to the butyrate-induced colonic hypersensitivity in mice. European Journal of Pharmacology. 999. 177660–177660. 1 indexed citations

Shintani, Yusuke, Atsuko Hayata‐Takano, Ichiro Takasaki, et al.. (2025). Rapid and long-lasting antidepressant-like effects of the pituitary adenylate cyclase-activating polypeptide receptor antagonist PA-915 in chronic stress mouse models. Molecular Psychiatry. 31(2). 1014–1026.

Nash, Robert J., et al.. (2024). Synthesis of 8-epi-l-swainsonine, related C6 alkylated derivatives and their α-l-rhamnosidase inhibition. Tetrahedron Letters. 139. 155008–155008. 1 indexed citations

Kobayashi, Eiji, Chihiro Motozono, Hiroshi Hamana, et al.. (2024). Characterization of Tumor-Infiltrating Lymphocyte-Derived Atypical TCRs Recognizing Breast Cancer in an MR1-Dependent Manner. Cells. 13(20). 1711–1711. 3 indexed citations

Okada, Takuya, et al.. (2024). Targeting Pancreatic Cancer with Novel Nicolaioidesin C Derivatives: Molecular Mechanism, In Vitro, and In Vivo Evaluations. Journal of Medicinal Chemistry. 67(16). 14313–14328. 2 indexed citations

Okada, Takuya, Ryusuke Sawada, Yoshihiro Yamanishi, et al.. (2023). Design and structural optimization of thiadiazole derivatives with potent GLS1 inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 93. 129438–129438. 2 indexed citations

Okada, Takuya, et al.. (2023). Concise Total Synthesis of rac‐Betuphenone F. European Journal of Organic Chemistry. 26(12). 3 indexed citations

Yokoyama, Takeshi, Mineyuki Mizuguchi, Yuko Nabeshima, et al.. (2023). Rafoxanide, a salicylanilide anthelmintic, interacts with human plasma protein transthyretin. FEBS Journal. 290(21). 5158–5170. 2 indexed citations

Tsuneki, Hiroshi, Masanori Sugiyama, Hisakatsu Ito, et al.. (2023). Resting phase-administration of lemborexant ameliorates sleep and glucose tolerance in type 2 diabetic mice. European Journal of Pharmacology. 961. 176190–176190. 1 indexed citations

10.

Baba, Hayato, Tomoyuki Okumura, Johji Imura, et al.. (2023). Nicolaioidesin C: An Antiausterity Agent Shows Promising Antitumor Activity in a Pancreatic Cancer Xenograft Mouse Model. Journal of Natural Products. 86(6). 1402–1410. 6 indexed citations

11.

Kato, Atsushi, Izumi Nakagome, Nobutada Tanaka, et al.. (2023). Design and Pharmacological Chaperone Effects of N-(4′-Phenylbutyl)-DAB Derivatives Targeting the Lipophilic Pocket of Lysosomal Acid α-Glucosidase. Journal of Medicinal Chemistry. 66(13). 9023–9039. 5 indexed citations

12.

Takasaki, Ichiro, Ai Watanabe, Takuya Okada, et al.. (2022). Design and synthesis of pyrido[2,3-d]pyrimidine derivatives for a novel PAC1 receptor antagonist. European Journal of Medicinal Chemistry. 231. 114160–114160. 10 indexed citations

13.

Sun, Sijia, Min Jo Kim, Dya Fita Dibwe, et al.. (2021). Anti-Austerity Activity of Thai Medicinal Plants: Chemical Constituents and Anti-Pancreatic Cancer Activities of Kaempferia parviflora. Plants. 10(2). 229–229. 17 indexed citations

14.

Sun, Sijia, Min Jo Kim, Dya Fita Dibwe, et al.. (2020). Chemical constituents of Callistemon citrinus from Egypt and their antiausterity activity against PANC-1 human pancreatic cancer cell line. Bioorganic & Medicinal Chemistry Letters. 30(16). 127352–127352. 19 indexed citations

15.

Sun, Sijia, Min Jo Kim, Dya Fita Dibwe, et al.. (2020). Fragranol A: A new class of spiro-triflavanoid hybrid with an unprecedented carbon skeleton from Anneslea fragrans. Tetrahedron Letters. 61(29). 152099–152099. 8 indexed citations

16.

Sun, Sijia, Min Jo Kim, Dya Fita Dibwe, et al.. (2020). Highly Potent Antiausterity Agents from Callistemon citrinus and Their Mechanism of Action against the PANC-1 Human Pancreatic Cancer Cell Line. Journal of Natural Products. 83(7). 2221–2232. 30 indexed citations

17.

Dibwe, Dya Fita, Sijia Sun, Min Jo Kim, et al.. (2020). Fragranone C: a new dihydrochalcone glucopyranoside from Anneslea fragrans twigs. Natural Product Research. 35(21). 3895–3900. 4 indexed citations

18.

Tsubota, Maho, Kaoru Yamaguchi, Junichi Tanaka, et al.. (2020). Cystitis-Related Bladder Pain Involves ATP-Dependent HMGB1 Release from Macrophages and Its Downstream H2S/Cav3.2 Signaling in Mice. Cells. 9(8). 1748–1748. 38 indexed citations

19.

Okada, Takuya, Fumiko Sekiguchi, Maho Tsubota, et al.. (2018). Design and synthesis of novel anti-hyperalgesic agents based on 6-prenylnaringenin as the T-type calcium channel blockers. Bioorganic & Medicinal Chemistry. 26(15). 4410–4427. 16 indexed citations

20.

Sekiguchi, Fumiko, Maho Tsubota, S. Yoshida, et al.. (2018). Critical role of Cav3.2 T-type calcium channels in the peripheral neuropathy induced by bortezomib, a proteasome-inhibiting chemotherapeutic agent, in mice. Toxicology. 413. 33–39. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact